Get a reply from this employer — a resume and cover letter tailored to exactly what they’re hiring for.
The New York State Institute for Basic Research in Developmental Disabilities (IBR) seeks an Institute Director to lead its research mission under the New York State Office for People with Developmental Disabilities.
This senior leadership role combines scientific oversight with strategic direction, guiding collaborations between basic researchers and clinicians to advance knowledge and improve services for individuals with IDD.
The New York State Institute for Basic Research in Developmental Disabilities (IBR) is recruiting for an Institute Director, an essential leadership position needed to continue the critical research of the institute and play a role in setting its course for the future. IBR is the research arm of the New York State Office for People with Developmental Disabilities (OPWDD). OPWDD is responsible for coordinating services for New Yorkers with intellectual and/or developmental disabilities (IDD), including intellectual disabilities, Down syndrome, autism spectrum disorders (ASD), rare genetic syndromes, and other neurological impairments. IBR is unique in that it provides a research environment conducive to collaboration between basic research scientists and clinicians. IBR is comprised of approximately 30 research laboratories and a unique, Article 16 Part 676 Diagnostic and Research Clinic which for over 50 years, has engaged in research and clinical work contributing to the field of Intellectual/Developmental Disabilities (IDD). IBR researchers played significant roles in discovering the genetic and biochemical defects that lead to Phenylketonuria (PKU) and subsequent development of newborn screening protocols and dietary guidance. The compound taurine, present in breast milk was discovered and patented at IBR as our researchers discovered its essential role in brain development. Monoclonal antibodies which play a role in the diagnosis, treatment and study of neurological diseases and developmental disabilities have been developed and patented at IBR. IBR was one of the leading laboratories to pinpoint the gene for amyloid precursor protein